{"id":"W2138077952","doi":"10.1016/s0140-6736(08)61206-4","title":"Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1068,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"Novo Nordisk; Amylin Pharmaceuticals; Eli Lilly and Company","keywords":"Exenatide; Medicine; Type 2 diabetes; Open label; Internal medicine; Diabetes mellitus; Randomized controlled trial; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004235463,0.002966331,0.00786141,0.0008977152,0.0006238088,0.00187786,0.001687272,0.004424007,0.01100616],"category_scores_gemma":[0.004640168,0.001589643,0.004022209,0.0008973496,0.002455764,0.002957509,0.0007994831,0.004217392,0.001363785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000765052,"about_ca_system_score_gemma":0.0008261069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007039497,"about_ca_topic_score_gemma":0.0008502938,"domain_scores_codex":[0.9979934,0.001133692,0.0001727403,0.0003197229,0.0001656314,0.0002148459],"domain_scores_gemma":[0.996536,0.001833935,0.0005197113,0.0004224581,0.00013415,0.000553767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9926947,0.002528443,0.0001065722,0.0003155709,0.0004812571,0.00002124157,0.00002282337,0.00007151433,0.0007843991,0.00004427858,0.00009048893,0.002838767],"study_design_scores_gemma":[0.9746104,0.0240819,0.0004476967,0.00001774949,0.0003861796,0.00001550242,0.00001260652,0.0001304538,0.00009767568,0.00009341804,0.00009325417,0.00001306925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855024,0.005405795,0.001329287,0.0007516932,0.001717346,0.002501509,0.0009126891,0.0001140761,0.001765165],"genre_scores_gemma":[0.9808193,0.004268254,0.002381037,0.0014436,0.001881485,0.003973208,0.0007242974,0.00005423565,0.004454469],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01100616,"threshold_uncertainty_score":0.03681934,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1022408823819575,"score_gpt":0.3476723919092116,"score_spread":0.2454315095272541,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}